Picture EBD Group BIO-Europe 2019 Partnering Report BEU2019 650x80px
Document › Details

Idorsia Ltd.. (2/6/18). "Press Release: Idorsia Announces Financial Results for 2017 – Company Off to a Great Start – 4 Compounds to Enter Phase 3 Development". Allschwil.

Organisations Organisation Idorsia Ltd. (SIX: IDIA)
  Group Idorsia (Group)
  Organisation 2 Roche (Group)
Products Product aprocitentan (ACT-132577)
  Product 2 nemorexant (proposed INN for ACT-541468)
Persons Person Clozel, Jean-Paul (Actelion 200607 CEO)
  Person 2 Muller, André C. (Idorsia 201706– CFO before Actelion 201309– CFO before Pierre Fabre CFO)

Record changed: 2018-02-16


Picture [LSA] – The Business Web Portal 650x89px

More documents for Idorsia (Group)

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


Picture EBD Group BIO-Europe 2019 Partnering Open BEU2019 650x80px

» top